Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognition and weight gain during antidepressant treatment
2017-004030-28Phase 4Completed
- Sponsor
- Psychiatric Research Unit, Region Zealand
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vortioxetine, citalopram, mirtazapine and topiramate in major depressive disorder (MDD), sponsored by Psychiatric Research Unit, Region Zealand. Primary endpoint: Depression remission (HAMD-17). Started Oct 2017; status: completed.
02
Drugs
vortioxetinecitaloprammirtazapinetopiramate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2017-004030-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004030-28.